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Brachytherapy consists of placing radioactive sources into or adjacent to tumors, to deliver
conformal radiation treatment. The technique is used for treatment of primary malig-
nancies and for salvage in recurrent disease. Permanent prostate brachytherapy seeds are
small metal implants containing radioactive sources of I-125, Pd-103, or Cs-131 encased in
a titanium shell. They can embolize through the venous system to the lungs or heart and
subsequently be detected by cardiovascular computed tomography. Cardiovascular
imagers should be aware of the appearance of migrated seeds, as their presence in the
chest is generally benign, so that unnecessary worry and testing are avoided. We report a
case of a patient who underwent brachytherapy for prostate cancer and developed a
therapeutic seeds embolus to the right ventricle.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Prostate cancer is a slow-growing exocrine gland neoplasm of
the reproductive system which most commonly affects men
of older age. Methods of prostate cancer management include
radical excision, hormone-mediated therapy, and radiation
therapy including brachytherapy [1,2]. It is of rare occurrence
for an emboli secondary to transmigration of brachytherapy
seeds, affixed to the prostate, to be localized in the heart of the
patient. On the contrary, embolus of seeds to other organs
(e.g., the lungs) is not uncommon [1,3,4]. For this reason,
cardiac imagers who do not also practice general thoracic
imaging may not be as familiar with the phenomena of seedlared that no competing
dechukwu).
Elsevier Inc. under copy
se (http://creativecommoembolization. Herein is a report of seed embolization to the
right heart diagnosed with gated cardiac computed tomogra-
phy. Review of the images provided should be sufficient to
educate cardiac imagers to identify this rare form of embolus.Case report
A 60-year-old male with known coronary artery disease pre-
sented to the emergency room with acute left-sided atypical
chest pain that varied in intensity with deep inspiration. Blood
D-dimer and troponin valueswere determined to be normal. An
electrocardiogram was obtained but showed only nonspecificinterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e CCTA pseudoaxial thin maximal intensity
projection image shows very high density focus within the
anterior wall of the right ventricle during the isovolemic
relaxation phase of systole. The arrow indicates the
location of the brachytherapy seeds.
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e32abnormalities. Cardiovascular computed tomography (CVCT) of
the thorax was performed at the request of the patient’s cardi-
ologist. A “triple rule out” protocol was used to enable opacifi-
cationof thepulmonaryarteries concurrentlywith theaortaand
coronary arteries. The CVCT reconfirmed atherosclerosis of theFig. 2 e PA and lateral radiograph of the chest with magnificatio
brachytherapy seeds.coronary arteries but was negative for flow-limiting lesion.
Furthermore, it was negative for pulmonary embolus, aortic
dissection, pneumonia, or other significant pathology. The pa-
tient’s pain resolved spontaneous, and the patient returned to
work theverynextday.Basedontheclinical course, thepainwas
diagnosed as musculoskeletal in origin.
The CVCT revealed an interesting incidental finding, two
tiny deposits of metal within the anterior wall of the right
ventricle. These deposits caused extreme beam and streak
artifacts relative to their tiny size and moved throughout the
cardiac cycle as if embedded in the parenchyma (Fig. 1, also
Cine 1 for electronic version). A review of prior chest radio-
graphs of the chest revealed, in retrospect, that these metal
deposits had been present at least 1 year prior (Fig. 2). The
patient did not have any prior history of thoracic intervention
or trauma. However, on close questioning, he reported that he
had undergone prostate seed implant brachytherapy several
years previously (Cine 2 for electronic version).Discussion
Use of permanent prostate brachytherapy has matured in the
last two decades and is now considered routine in the man-
agement of low-grade, low-stage prostate cancer. Permanent
brachytherapy procedures involve transperineal ultrasound-
guided insertion of “seeds” containing radioactive sources
Palladium-103 (Pd-103) or Iodine-125 (I-125). Pd-103 has a
shorter half-life (17 days, compared to 59 days for I-125),
allowing a higher initial dose that may be more effective in
faster growing tumors [1]. I-125, the more commonly used
isotope, is lower in cost and more easily available.n view of the heart. The arrows indicate the location of the
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cal and 4-4.5 mm long with a diameter of 800 micrometers [2].
An inert titanium casing contains both the radioactivematerial
andasmallamountofgold foil toensureeasyvisualizationwith
both fluoroscopy and computerized tomography. Seeds are
often placed near or outside the prostatic capsule, to ensure an
adequate dose of radiation is delivered to the periphery of the
prostate (Fig. 3, also Cine 2 for electronic version). The prostate
is surrounded by a dense venous plexus as such seeds which
erode into this vasculature or are originally implantedwithin it
canmigrate hematogenously to other sites [3].
Thehighest reported incidenceof seedmigrationhas been to
the pulmonary vasculature. In a single case study, Ankem et al.
[3] demonstrate that seed migration can occur in 36.2% of pa-
tients undergoing prostate brachytherapy. For this reason,
guidelines issued by the American Brachytherapy Society
recommend counseling patients about the possibility of
implants migrating to the lungs [4]. Some investigators have
been concerned that this phenomenon can decrease radiation
dose to the prostatemalignancyandadversely affect lung tissue
[1].However, the lossof2e4seedsdoesnot significantlyalter the
prostate dosimetry, and the calculated dose of radiation to the
lung tissue in this scenario, between20e30keVper 1 cm3of lung
tissue, was found to have a minimal effect on pulmonary func-
tionduetotheshorthalf livesof theradioactive isotopesused [1].
There are sparse reports of unusual sequelae of seed
migration. Single examples of radiation pneumonitis, acute
myocardial infarction, and small-cell lung cancer associated
with seed migration to the thorax have been reported [5e7].
Migration of seeds directly into the parenchyma of the right
ventricle, as with the case detailed herein, has been reported
and proven previously at autopsy, although rare [2]. Most
concerns of these reports are related to fear of secondary
malignancy or mortality from the radiation effect and embo-
lization, respectively. However, a number of convincingFig. 3 e Thick maximal intensity projection series derived
from a CT Urogram of the prostate shows prostate seeds in
situ (different patient). The arrow indicates the location of
the brachytherapy seeds.studies on the phenomenon of seedmigration have concluded
that the risk of any morbidity is negligible [8e11].Conclusion
The finding of prostate seed embolization to the heart or lungs
is not an indication for subsequent scanning as the reports of
possible detrimental risks have been low. Regardless, health
care providers should be educated on the appearance of
migrated seeds to maintain awareness of its possibility and
decrease unnecessary follow-up and testing.Supplementary data
Supplementary data associated with this article can be found
in the online version, at http://dx.doi.org/10.1016/j.radcr.2
016.10.009.r e f e r e n c e s
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